Furthermore, it is known that ERα activation through phosphorylation of Ser167 in an estrogen-independent manner and FGFR activation can cause TAM resistance: both proteins were identified within our BC-PDMs TAM resistance panel [76, 80, 112]. Here, ESR1 is linked to breast cancer.